[1] Houdek MT, Wyles CC, Martin JR,et al. Stem cell treatment for avascular necrosis of the femoral head: current perspectives.Stem Cells Cloning. 2014;9(7):65-70.
[2] BrinkrMR, RosenbergAG, Kull L, et al. primary total hip arthroplasty using noncemented porous coated femoral components in patients with osteonecrosis of femoral head.J Arthroplasty.1994;9:457-468.
[3] Sugioka Y,Hotokebuchi T,Tsutsui H.Transtroehanteric anterior rotational osteotomy for idiopathic and steroid-induced neerosis of the femoral head. Clin Orthop Relat Res. 1992;277:111-120.
[4] Mont MA,Fairbank AC,Krackow KA ,et al. Corrective osteotomy for osteonecrosis of the femoral head.J Bone Joint Surg(AM).1996;78:1032-1038.
[5] Dean MT,Cabanela ME.Transtroehanteric anterior rotational osteotomy for avaseular necrosis of femoral head long term results.J Bone Joint Surg(Br).1993;75(4):597-601.
[6] Yassunaga Y,Hisatome T,Ikuta Y,et al. A histological study of the necrotic area after transtrochanteric anterior rotational osteotomy for osteonecrosis of the femoral head. J Bone Joint Surg(Br).2001;83(2):167-170.
[7] Moriyama M, Moriyama H, Ueda A, et al. Human adipose tissue-derived multilineage progenitor cells exposed to oxidative stress induce neurite outgrowth in PC12 cells through p38 MAPK signaling. BMC Cell Biol.2012;7(13):21.
[8] Zuk PA,Zhu M,Ashjian P, et al.Human adipose tissue is a source of multipotent stem cells.Mol Biol Cell. 2002;13(12): 4279-4295.
[9] 王晓锋,吴岩.骨组织工程中干细胞的研究与应用[J]. 中国组织工程研究,2013,17(9):3558-3565.
[10] Nishimori M, Yamada Y, Hoshi K, et al. Health-related quality of life of unrelated bone marrow donors in Japan. Blood. 2002; 99(6):1995-2001.
[11] Lennon DP, Haynesworth SE, Arm DM,et al. Dilution of human mesenchymal stem cells with dermal fibroblasts and the effects on in vitro and in vivo osteochondrogenesis. Dev Dyn. 2000;219(1):50-60.
[12] Hoemann CD, El-Gabalawy H, McKee MD.In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization.Pathol Biol (Paris). 2009;57(4):318-323.
[13] 杨志明.组织工程基础与临床[M].成都:四川科学技术出版社, 2003:4-20.
[14] 李彦林,杨志明,解慧琪,等.生物衍生组织工程骨支架材料的制备及理化特征[J].生物医学工程学杂志,2002,19(1):10-12.
[15] Thakkar H,Sharma RK,Mishra AK,et al.Efficacy of chitosan microspheres for controlled intra-articular delivery of celecoxib in inflamed joints.J Pharm Pharmacol 2004;56(9): 1091-1099.
[16] 盛贻林,叶舟,陈奇,等.壳聚糖及其衍生物的抑菌试验研究[J].中国医药生物技术,2011,6(1):56-58.
[17] Xia W,Liu W,Cui L,et al.Tissue engineering of cartilage with the use of chitosan-gelation complex scaffolds.Biomed Mater Res B Appl Biomater. 2004;71(2):373-380.
[18] Lahiji A,Sohrabi A,Hungerford DS,et al.Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes.Biomed Mater Res. 2000; 51(4):586-595.
[19] Ong SY, Wu J, Moochhala SM, et al. Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties. Biomaterials. 2008;29(32): 4323-4332.
[20] Sung JH, Hwang MR, Kim JO ,et al.Gel characterization and in vivo evaluation of minocycline-loaded wound dressing with enhanced wound healing using polyvingl alcohol and chitosan. Int J Pharm. 2010;392(1-2):232-240.
[21] 高文彪,张岩睿,张军.胶原/壳聚糖止血敷料在外科伤口中的应用[J].中国组织工程研究,2012,16(29):5477-5480.
[22] 邓守恒,柯贤柱,杨敬宁,等.硒化壳聚糖促创面愈合作用的体内研究[J].中国美容医学,2012,21(1):55-58.
[23] 梁晔,韩宝芹,刘万顺,等.角膜内皮细胞载体壳聚糖基共混膜的制备及性质研究[J].功能材料,2011,42(11):2009-2013.
[24] 马群,刘万顺,韩宝芹,等.角膜组织工程支架壳聚糖基共混膜的制备及性能评价[J].功能材料,2010,41(9):1547-1551.
[25] Cooper A, Bhattarai N, Kievit FM,et al.Electrospinning of chitosan derivative nanofibers with structural stability in an aqueous environment. Phys Chem Chem Phys. 2011;13(21): 9969-9972.
[26] 郑磊.壳聚糖神经导管及其复合骨髓间充质干细胞修复大鼠周围神经损伤的研究[D].济南:山东大学,2009.
[27] Yan J, Yang L, Wang G,et al. Biocompatibility evaluation of chitosan-based injectable hydrogels for the culturing mice mesenchymal stem cells in vitro. J Biomater Appl. 2010;24(7): 625-637.
[28] 钱超,郭杨,马勇.骨组织工程中成骨、破骨细胞三维空间培养的研究进展[J].安徽医科大学学报,2014,49(2):280-282.
[29] 黄长智,杨效宁,刘大诚,等.降钙素基因相关肽诱导藻酸钙凝胶复合脂肪干细胞的成骨细胞分化[J].中国组织工程研究. 2013, 17(42): 7356-7362.
[30] 李艺楠,李广峰,冯新民,等.骨髓间充质干细胞复合温敏水凝胶支架的制备[J].中国组织工程研究,2013,17(42):7435-7441.
[31] 黄成,杨建东,冯新民,等.季铵盐壳聚糖三维支架复合GNDF载间充质干细胞向神经样细胞分化[J].中国组织工程研究. 2013, 17(42): 7420-7426.
[32] Kim H, Tator CH, Shoichet MS. Chitosan implants in the rat spinal cord: biocompatibility and biodegradation. J Biomed Mater Res A. 2011;97(4):395-404.
[33] Uskokovi? V, Desai TA.In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.J Pharm Sci. 2014;103(2):567-579.
[34] Muzzarelli RA.Chitins and chitosans as immunoadjuvcants and non-allergenic drug carriers.MarDrugs. 2010;8(2): 292-312.
[35] Zhang L, Wang M, Kang X, et al. Oxidative stress and asthma: proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid. J Proteome Res. 2009;8(4):1631-1638. |